MPLT
MapLight Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$8.00
+3.90%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-66.0%
Return on equity
-62.4%
Return on assets
-69.4%
Return on invested capital
0.00x
Asset turnover
-$174.7M
Cash from operations
$5.48
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026